Treatment of Refractory Tumor Necrosis Factor Inhibitor–Induced Palmoplantar ... Archives of Dermatology 2-4 Ustekinumab, type A relatively new medication for the treatment of disease of the skin , has also incontestible promise. A small suit series of patients with recalcitrant PPP treated with ustekinumab suggests that it may allow for bit-by-bit improvement of disease. ... Link To Article
No comments:
Post a Comment